BioXcel Therapeutics, Inc.
BTAIQ- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001720893
No open-market purchases or sales by BioXcel Therapeutics, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $8.69M in total; Oaktree Capital is the only superinvestor holding it.
13F holders, Q2 2022
Institutional positions in BioXcel Therapeutics, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 94
- −1 vs. Q1 2022
- Shares held
- 12.7M
- −413.8K (−3.2%) vs. Q1 2022
- Total value
- $167.4M
- −$106.4M (−38.9%) vs. Q1 2022
- New holders
- 15
- 32 more added
- Sold out
- 16
- 28 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BTAIQ on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 47 | $8.69M |
| Q1 2026 | 40 | $7.28M |
| Q4 2025 | 41 | $5.66M |
| Q3 2025 | 35 | $6.05M |
| Q2 2025 | 35 | $1.09M |
| Q1 2025 | 31 | $769.7K |
| Q4 2024 | 49 | $3.22M |
| Q3 2024 | 50 | $1.89M |
| Q2 2024 | 74 | $12.5M |
| Q1 2024 | 74 | $26.1M |
| Q4 2023 | 73 | $27.6M |
| Q3 2023 | 86 | $25.8M |
| Q2 2023 | 88 | $117.8M |
| Q1 2023 | 97 | $325.0M |
| Q4 2022 | 84 | $288.9M |
| Q3 2022 | 85 | $140.3M |
| Q2 2022 | 94 | $167.4M |
| Q1 2022 | 96 | $273.9M |
| Q4 2021 | 93 | $283.1M |
| Q3 2021 | 104 | $388.3M |
| Q2 2021 | 109 | $378.6M |
| Q1 2021 | 118 | $475.2M |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding BioXcel Therapeutics, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Simplex Trading, LLC | 0 | $0 | 0.00% | −17,598−100.0% | Sold out |
| Capital Investment Advisory Services, LLC | 0 | $0 | 0.00% | −14,075−100.0% | Sold out |
| HITE Hedge Asset Management LLC | 0 | $0 | 0.00% | −12,768−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −12,600−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −5,428−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,823−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −75−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −96−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| CWM, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |